Pharmacologic treatments for covid-19 patients

Remdesivir 5 days vs Remdesivir 10 days


Hospitalized patients

Forest plots
(last update: 2021-04-08)

Summary of findings
(last update: 2021-05-10)

To access all information :

You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.

Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=24

Back to your research

Trial Funding Comparisons Design Participants Sample size Overall risk
of bias
Highest assessment
Full description
Treatment 1 Treatment 2
NCT04292730
Spinner CD, JAMA, 2020
Full text
Commentary
Private

Remdesivir

Remdesivir

Remdesivir

Standard care

Standard care

Remdesivir

RCT Patients with COVID-19 (mild-severe) admitted to 105 centers in the USA, Europe and Asia N=596
Some concerns
Details

Full description

NCT04292899
Goldman JD, N Engl J Med, 2020
Full text
Results in clinicaltrials.gov
Full text
Commentary
Commentary
Private

Remdesivir 5 days

Remdesivir 10 days

RCT Patients with confirmed COVID-19 (moderate to critical) admitted to 55 centers across 5 countries. N=402 N/A

Full description